Breakthrough Fellowship
The Leukaemia Foundation’s Breakthrough Fellowships are the flagship funding initiative of our National Research Program.
This prestigious research fellowship represents our unwavering commitment to supporting the next generation of our country’s brightest researchers and clinicians. By investing in the best, we’ll deliver improved outcomes for Australians with blood cancer and save more lives.
Tour de Cure is our inaugural Breakthrough Fellowship partner, pledging $2M over five years. The Leukaemia Foundation is matching this life-saving investment, making it one of our largest and most important commitments to blood cancer research.
Our Breakthrough Fellowship recipients have been selected because they are taking bold steps as leaders in Australia’s blood cancer ecosystem.
They are established researchers, recognised and assessed by their peers, who have made significant contributions to the way we treat and care for people living with blood cancer.
We know significant innovation comes as a direct result of investment in people and research. These fellowships ensure talented change-makers are taking the next steps in their careers to help transform the lives of people facing blood cancer.
Read about the latest recipients of our Breakthrough Fellowships:
- Dr Ashwin Unnikrishnan is looking past standard chemotherapy towards new and more effective approaches to treating acute myeloid leukaemia
- Dr Ashley Ng is leading advanced research to improve our understanding of treatment-resistant acute lymphoblastic leukaemia and develop new ways of beating it